Sang Min Lim

Title: Sang Min Lim: Innovator in Pharmaceutical Chemistry

Introduction

Sang Min Lim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating neurodegenerative diseases.

Latest Patents

Sang Min Lim holds two notable patents. The first patent is for a novel halo-(3-(phenylsulfonyl)prop-1-enyl)pyridine derivative and its use. This invention relates to a preparation method and includes an Nrf2 activator, which is crucial for preventing or treating diseases caused by decreased Nrf2 activity. The second patent involves a levosimendan compound, which is used for preventing or treating tau-related diseases, including neurodegenerative conditions such as Alzheimer's disease. This patent also encompasses health functional foods that contain the levosimendan compound.

Career Highlights

Throughout his career, Sang Min Lim has worked with notable organizations, including Cureverse Incorporated and the Korea Institute of Science and Technology. His work has focused on innovative solutions in the pharmaceutical sector, contributing to advancements in medical treatments.

Collaborations

Sang Min Lim has collaborated with esteemed colleagues, including Ae Nim Pae and Ki Duk Park. These partnerships have fostered a collaborative environment that enhances research and development in his field.

Conclusion

Sang Min Lim's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in treatments for neurodegenerative diseases.